Fighting Multidrug-Resistance with Biodegradeable Nanoparticles
07/21/2016
Researchers from Northeastern University, the Roger Williams Medical Center, Massachusetts General Hospital, and Massachusetts Institute of Technology (all part of a NCI Cancer Nanotechnology Platform Partnership) focus on nanotherapeutic strategy for multidrug-resistant tumors. In this image, multifunctional biodegradable nanoparticles were used to administer agents directly into cells. Researchers hope to be able to deliver anticancer therapies through this mechanism.
No hay comentarios:
Publicar un comentario